Willow NAD+ review

Messaging access is the most concrete attraction

Willow’s NAD+ page describes physician review, pharmacy preparation, tracked delivery and unlimited doctor messaging. It also lists round-the-clock Care Team support. ^[1] For a home prescription, that is a more useful reason to consider the service than its promises about feeling sharper or more restored.

I would shortlist Willow for a reader who wants a clear communication route and is prepared to ask what the clinician expects treatment to achieve. The public page makes the intended delivery format understandable and advertises $199 per month for NAD+. ^[1] That is a useful price to take into a comparison, provided the selected supply and recurring agreement are clear. A service can explain access well while still needing a more specific quote before its complete value can be judged.

This is a subcutaneous prescription offer

The provider describes NAD+ as a small subcutaneous injection and outlines an initial schedule followed by clinician-guided options. ^[1] That is Willow’s program description, rather than a schedule this review recommends. The actual instructions should come from the prescriber and dispensing pharmacy for the supplied preparation.

Keep the route visible when comparing alternatives. An oral NR capsule, NAD nasal spray and intravenous session create different practical commitments. They also do not inherit one another’s research results automatically. An injection can be convenient for one person and unwelcome for another, even before the evidence question is considered. A good fit depends on willingness to handle the actual treatment, with a clear plan for questions after delivery.

Read our NAD delivery-format guide for the next part of the decision.

The $199 figure belongs to the NAD+ offer

The NAD+ treatment page advertises $199 per month. ^[1] This is a product-specific figure, so there is no reason to substitute the separate FAQ’s starting GLP-1 subscription price. A monthly advertisement still needs to be matched to the prescribed preparation, quantity, included care and billing agreement. Those details determine whether two services are quoting comparable purchases.

Request a quote that identifies the first payment, recurring payment, amount supplied and renewal interval. It should also explain what happens if the clinician recommends a different quantity or decides treatment is inappropriate. These questions matter even when the headline monthly price is clear. Compare Willow’s advertised $199 with another provider only after checking both selected prescriptions and commitments; the lower visible number need not describe the lower complete bill.

A stronger route claim needs a stronger comparison

Willow suggests its prescription approach can provide more consistent support than over-the-counter options. ^[1] I would treat that as the provider’s pitch, not a demonstrated superiority finding. A direct comparison would need to test the actual preparations and a meaningful outcome in comparable participants.

The small published intravenous NAD pilot assessed changes in blood and urine measurements around an infusion. It did not test Willow’s home injection program against NR supplements or establish improved day-to-day cognition. ^[3] That distinction matters when the marketing makes delivery sound like the deciding scientific advantage. The route tells the reader how the product is used. It does not by itself tell the reader how much better they will feel.

Read our human infusion evidence review for the next part of the decision.

The platform and clinical service have different roles

Willow’s terms distinguish the technology platform from the affiliated physicians and pharmacy services, and make prescription availability conditional on clinical judgment. ^[4] This is useful context for understanding whom the patient needs to contact. The person resolving a billing issue may be different from the person deciding whether to continue treatment.

I would ask how a patient reaches the prescriber and how quickly medication concerns are triaged. Unlimited messaging describes access; it should not be interpreted as an immediate response guarantee. The NAD page also describes review usually within 24 hours. ^[1] That is a service expectation, not proof that every prescription, pharmacy step and delivery finishes within a day.

The sensible fit is an informed, flexible buyer

The FAQ describes automatic renewal and a cancellation cutoff at least two business days before processing. ^[2] Confirm the agreement attached to the NAD order, including the refund boundary and what happens after a prescription reaches the pharmacy. A general promise of flexible cancellation should be read with those actual dates and events beside it.

My verdict is that Willow has a practical appeal in its physician messaging, defined injection pathway and a stated $199 monthly NAD+ rate. Compare it with a prescription-specific agreement in view. Choose it for a service arrangement that fits your needs, with modest expectations about benefit. If the reason for buying is a promise that injections outperform oral options for energy or focus, the evidence reviewed here does not settle that claim.

Read our CoreAge versus AgelessRx comparison for the next part of the decision.

Understanding the cost

The NAD+ page advertises $199 per month. Confirm the exact preparation, supply, first charge, included care and renewal terms for the selected prescription. ^{[1] [2]}